DHEA (Dehydroepiandrosterone) in RRM

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated May 14, 2026

DHEA (dehydroepiandrosterone) supplementation refers to the clinical use of this androgen precursor hormone to address low androgen levels in women with diminished ovarian reserve or related reproductive conditions. DHEA is produced primarily by the adrenal glands and serves as a precursor to both estrogen and testosterone. In the ovarian microenvironment, adequate androgen signaling supports follicular development and granulosa cell function. When androgen levels are low, follicular maturation may be impaired, and some clinicians consider DHEA supplementation as part of a broader restorative evaluation.¹

The evidence base for DHEA in reproductive medicine is mixed. Several meta-analyses have examined DHEA supplementation in women with poor ovarian response or diminished ovarian reserve (DOR), reporting modest improvements in ovarian response markers such as antral follicle count and oocyte yield. The evidence for improvement in live birth rate is less consistent and requires further investigation in well-designed trials.¹ Assessment of AMH and other ovarian reserve markers typically informs whether DHEA supplementation is relevant for a given patient.

Within restorative reproductive medicine, DHEA is used selectively by some named clinical methods. NeoFertility includes androgen evaluation as part of its expanded diagnostic panel, and DHEA supplementation may be considered when hypoandrogenemia is identified as a contributing factor. NaPro Medical similarly evaluates hormonal contributors to subfertility within a cycle-informed framework, and restorative androgen support may be part of that individualized assessment. The specific indication, timing, and approach are determined by the evaluating clinician based on the patient's full hormonal picture, not by a single field-wide protocol.

DHEA supplementation is not a standalone therapy. Its potential role is always considered in the context of identifying why ovarian reserve is diminished, which may involve thyroid function, nutritional status, immune factors, or other underlying conditions. This root-cause orientation distinguishes restorative use of DHEA from its application as a routine adjunct in ART stimulation protocols.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.